Our bodies are extremely efficient at storing fat from food into our fat tissue. In a new study, researchers from the University of Copenhagen have managed to completely block the development of obesity.
The researchers deleted an enzyme and made it impossible for mice to increase their amount of fat tissue, despite the mice eating an extremely fatty diet. They are hoping the findings will open new avenues for better treatment of obesity.
But today, where many of us have constant access to high calorie foods, our body’s impressive ability to convert food into fat has, ironically, become problematic. Consequently, the number of overweight people worldwide is skyrocketing, leading to large health consequences for both the individual and society.
However, as part of a new study, researchers at the University of Copenhagen have now managed to inhibit the body’s ability to store fat. They genetically delete the enzyme NAMPT in fat tissue of mice, and this renders the animals completely resistant to becoming overweight or obese, even on a very fatty diet.
‘We gave the mice a diet that more or less corresponds to continuously eating burgers and pizza. Still, it was impossible for them to expand their fat tissue. Our ultimate goal is that by understanding these fundamental underpinnings of how we become obese, we can apply our finding to the development of novel treatment strategies for metabolic disease,’ says Karen Nørgaard Nielsen, first author on the publication and a Ph.D. student at the Novo Nordisk Foundation Center for Basic Metabolic Research.
High-Fat Food, Same Weight
The findings are in line with results obtained from humans. Several studies have shown that the presence of large amounts of the enzyme NAMPT in blood and in stomach fat tissue is significantly connected with being overweight or obese. However, this study provides the first evidence that NAMPT is absolutely required to become overweight or obese and that lack of NAMPT in fat tissue fully protects against obesity.
In the University of Copenhagen study, the researchers compared how normal mice and mice lacking NAMPT in fat tissue gained weight when given either high-fat food or a healthier, lower-fat diet. When on the healthy diet, there was no difference in body weight or the amount of fat between the normal mice and the mice lacking NAMPT.
However, when the mice were given high-fat food, the control mice became very obese, yet the mice lacking NAMPT gained no more weight from high-fat food than when they were on the healthier diet. In addition, the mice lacking NAMPT maintained better control of blood glucose than normal mice when eating high-fat food.
Contradicts the General View
The result challenges the general view of NAMPT, which is largely seen as an enzyme that should be boosted for therapeutic purposes.
‘NAMPT appears to increase the metabolic functionality of almost every tissue in the body in which it has been studied. For example, there are indications that the liver and skeletal muscle may benefit from increased NAMPT activity. We similarly find that NAMPT is critical for fat tissue function. Unfortunately, that function is efficiently storing fat. NAMPT in fat tissue was likely once an extraordinary benefit to our ancestors but in today’s society full of high-fat, calorically-dense foods, it may now pose a liability’, says Associate Professor Zachary Gerhart-Hines from the Novo Nordisk Foundation Center for Basic Metabolic Research and corresponding author on the study.
He does not necessarily believe that generally decreasing NAMPT is a viable treatment strategy in humans. There would be too great a risk for potentially harmful consequences in other tissues of the body.
However, he suggests that this study may pave the way for more research into how NAMPT is linked to the storage of fat from the food we eat. By learning biologically how we become obese in the first place, he hopes that it will eventually be possible to target one of the underlying mechanisms in humans to treat obesity and metabolic disease.
Learn more: Researchers Defy Biology: Mice Remain Slim on Burger Diet
The Latest on: Obesity
[google_news title=”” keyword=”obesity” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Obesity
- Rio de Janeiro tests new recipe against childhood obesityon April 30, 2024 at 1:39 am
Chicken with potatoes, carrot-and-cabbage salad: it looks like a detox meal, but it's the menu at a school cafeteria in Rio de Janeiro, Brazil, which is seeking new ways ...
- Changes coming to school meals to help combat rising children obesityon April 29, 2024 at 11:06 am
Obestity among children in the united states is rising. With one in five tipping the scales as overweight.With many children eating at least ...
- Curbing the price of novel diabetes and obesity medicationson April 29, 2024 at 10:12 am
For years, Kasia Lipska, MD, MHS, associate professor of medicine (endocrinology) at Yale School of Medicine (YSM), has been advocating for affordable pricing of insulin, an essential —and sometimes ...
- Drinking fruit juice as a child can stop obesity later in life, new research suggestson April 29, 2024 at 9:55 am
The Swansea University research followed 14,000 British children from birth to adulthood and is believed to be the longest of its kind ever reported.
- Drinking fruit juice as a kid could prevent obesity later in life: studyon April 29, 2024 at 9:17 am
A new study has discovered that having soft drinks like cola before the age of two can cause weight gain in your twenties.
- Get Healthy: Healthy eating, robust activity can combat growing problem of childhood obesityon April 29, 2024 at 6:30 am
Exercise has added benefits of boosting mood and improving heart health. “Doing activities as a family or in a group, when possible, may motivate children to stay active,” said Vora, suggesting that ...
- What’s Next for Obesity Therapeutics? Higher Quality Weight Losson April 28, 2024 at 9:04 pm
With GLP-1 agonists slated to become the best-selling drugs in 2024, the biopharma industry is already pivoting to explore treatments that preserve muscle mass as patients shed pounds.
- Novo Nordisk (NYSE:NVO) and Eli Lilly (NYSE:LLY): Anti-Obesity Drug Market Could Reach Double Current Projections, Says Health Care Analyston April 28, 2024 at 4:56 pm
Citi Analyst Andrew Baum M.D. says the weight loss market could reach double the current projections of $160 billion in peak sales for diabetes and obesity combined.
- Big Pharma’s dogfight to dominate the anti-obesity marketon April 27, 2024 at 7:18 pm
Around the world, 100 companies have debuted weight-loss medications, which have become a multimillion-dollar business. Novo Nordisk’s Ozempic is currently the best-known, but it’s far from the only o ...
via Bing News